微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -0.76% | -72.73% | 46.1% | 113/140 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -1.41% | 59.01% | -67.86% | 100/140 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -0.84% | -147.06% | -127.03% | 110/140 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -0.37% | -159.68% | 15.91% | 103/140 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -0.44% | -162.86% | 87.21% | 114/140 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -3.44% | 11.11% | -911.76% | 112/140 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | -0.34% | -140% | -154.84% | 111/140 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.62% | 6.9% | -11.43% | 92/140 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.7% | 400% | 118.09% | 85/140 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -3.87% | -121.74% | -555.29% | 115/140 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 0.85% | -94.65% | 46.55% | 105/140 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.58% | -95.25% | 314.29% | 107/140 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.14% | -97.99% | -99.21% | 108/140 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 17.8% | -17.05% | 11.95% | 34/140 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 15.9% | -11.07% | 30.11% | 29/140 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 12.22% | -5.93% | 75.83% | 28/140 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 6.95% | -36.47% | -67.61% | 20/140 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 21.46% | -76.47% | 20.02% | 36/140 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 17.88% | -76.79% | 37.64% | 31/140 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 12.99% | -75.91% | 18.74% | 32/140 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 10.94% | -32.68% | -88% | 13/140 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 91.2% | 1048.62% | 18.4% | 11/140 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 77.03% | 2% | 42.86% | 5/140 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 53.92% | 1011.75% | 231.82% | 8/140 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 16.25% | 2% | 104.66% | 2/140 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 7.94% | -20.76% | 63.71% | 89/140 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | 4.85% | 8.74% | -51.6% | 47/140 | 6.76% | 祥生医疗 | 28.56% | 行业排名> |
| 2018-12-31 | 10.02% | 13.61% | 124.66% | 73/140 | 14.23% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-06-30 | 4.46% | 25.99% | -49.43% | 33/140 | 4.54% | 新华医疗 | 13.55% | 行业排名> |
| 2017-12-31 | 8.82% | 2.32% | 149.15% | 70/140 | 14.51% | 安旭生物 | 48.71% | 行业排名> |
| 2017-06-30 | 3.54% | 18.39% | -58.93% | 41/140 | 6.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2016-12-31 | 8.62% | -32.39% | 188.29% | 57/140 | 16.44% | *ST明德 | 14.54% | 行业排名> |
| 2016-06-30 | 2.99% | 2% | -76.55% | 39/140 | 6.35% | 迈瑞医疗 | 11% | 行业排名> |